Opendata, web and dolomites
H2020 projects about "hepatic"
The page lists 41 projects related to the topic "hepatic".
| # | |||
|---|---|---|---|
| 1 | EPoS | Elucidating Pathways of Steatohepatitis | 2015 |
| 2 | LiVirIn | 3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction | 2015 |
| 3 | PATOX | Development of pyrrolizidine alkaloid detection methods for the assessment of food contamination and impact on human and animal health | 2016 |
| 4 | REZONABLE | Regeneration and zonation by ZEB2 of Liver Endothelium | 2016 |
| 5 | EPIRIN | EPIGENETIC REGULATION OF INFLAMMATION IN NAFLD | 2015 |
| 6 | Liver Bioengineering | Ex vivo Re-vascularization in Porcine Liver Bioengineering - A Critical First Step Towards Effective Transplantation of Bioengineered Livers | 2015 |
| 7 | InCisive | creTRAP for in situ Characterization of Fibrosis-Promoting Pathways in Non-alcoholic Fatty Liver Disease | 2016 |
| 8 | INNOPREFAT | Natural Food formulation for the prevention and treatment the Obesity and Metabolic syndrome obtained with herbal extracts | 2015 |
| 9 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 10 | ChiLTERN | Children’s Liver Tumour European Research Network | 2016 |
| 11 | DeMILI | NON INVASIVE DIAGNOSTIC TEST SERVICE FOR “NON ALCOHOLIC FATTY LIVER DISEASE” MANAGEMENT | 2016 |
| 12 | CollBioImag | Development of a cell-based system for high-throughput screening of antifibrotics | 2016 |
| 13 | GCG-T3 Dyslipidemia | Validation and Molecular Characterization of Novel Glucagon-Thyroid Hormone Conjugates for the Efficient Management of Dyslipidemia and Fatty Liver Disease | 2016 |
| 14 | SiCMetabol | Signaling Cascades in Metabolic Diseases | 2016 |
| 15 | HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC | 2016 |
| 16 | Relieve-Chol | Reprogramming cell identity to develop new therapies against Cholangiopathies | 2016 |
| 17 | TGDNL | Mechanisms of cellular fatty acid homeostasis | 2017 |
| 18 | Foie Gras | Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease | 2017 |
| 19 | EXNADMINA | EXercise as a regulator of hepatic NAD metabolism and MItochondrial function in Non-Alcoholic fatty liver disease | 2016 |
| 20 | LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS | 2017 |
| 21 | LiSDMA | Liver steatosis drives muscle atrophy in type 2 diabetes patients. | 2018 |
| 22 | TOXANOID | Pharmacological safety testing in human adult stem cell-derived organoids | 2017 |
| 23 | ONCOSYSTEMS | Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers | 2017 |
| 24 | KupfferCellNiche | Determining the instructive tissue signals and the master transcription factors driving Kupffer cell differentiation | 2017 |
| 25 | VOLIV | Role of volume-regulated anion channels in liver physiology and metabolism | 2019 |
| 26 | VitC | Structural studies of the full-length human Vitamin C transporters: unravelling Vitamin C transport across the membrane | 2018 |
| 27 | OSTtrans | The Role of OSTα/β as a Bile Acid and Drug Transporter in Obesity-Associated Chronic Liver Disease, Nonalcoholic Fatty Liver Disease | 2018 |
| 28 | SCOPIO | High-resolution, all-digital microscope that applies computational methods to bring revolutionary benefits of digital microscopy to small and medium sized laboratories | 2018 |
| 29 | BARINAFLD | Using Bariatric Surgery to Discover Weight-Loss Independent Mechanisms Leading to the Reversal of Fatty Liver Disease | 2018 |
| 30 | TransReg | Transgenerational epigenetic inheritance of cardiac regenerative capacity in the zebrafish | 2019 |
| 31 | ArtHep | Hepatocytes-Like Microreactors for Liver Tissue Engineering | 2019 |
| 32 | VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | 2019 |
| 33 | LIV-AD-ON-CHIP | Unmasking insulin resistance triggering mechanisms using microphysiological two-organ systems as in vitro disease models of metabolic syndrome and non-alcoholic fatty liver disease | 2020 |
| 34 | BodyDMI | Development of deuterium metabolic imaging to map body biochemistry with MRI | 2019 |
| 35 | LiverMacRegenCircuit | Elucidating the role of macrophages in liver regeneration and tissue unit formation | 2020 |
| 36 | Hepatic Thermogenesi | Study the functions of the hepatic sympathetic nerve and the receptor Adrb3 in liver-mediated adaptive thermogenesis. | 2019 |
| 37 | INVADERS | Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease | 2019 |
| 38 | ENDOGI | The first multiple stent delivery system for the treatment of biliary, pancreatic and urologic strictures and stenosis | 2019 |
| 39 | MyeFattyLiver | Unravelling the heterogeneity and functions of hepatic myeloid cells in Non-Alcoholic Fatty Liver Disease | 2019 |
| 40 | DECISION | DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES | 2020 |
| 41 | MacinNASH | Revealing the contribution of liver macrophage populations to NASH in insulin resistance | 2020 |